Financial News
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
By:
Johnson & Johnson via
Business Wire
February 12, 2024 at 16:10 PM EST
Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs after the webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240212450230/en/
Contacts
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com
More News
View More
Bitcoin and Dividends: A Winning Combo in These 3 ETFs
August 02, 2025
Is PG&E an AI Power Play? Why Options Traders Are Betting Big
August 02, 2025
MarketBeat Week in Review – 07/28 - 08/01
August 02, 2025
Will Hims & Hers Fall Along With Novo Nordisk?
August 01, 2025
Via MarketBeat
Play It Cool: Why Comfort Systems USA Is a Hidden AI Winner
August 01, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.